210 related articles for article (PubMed ID: 20579076)
1. Targeting solid tumors with non-pathogenic obligate anaerobic bacteria.
Taniguchi S; Fujimori M; Sasaki T; Tsutsui H; Shimatani Y; Seki K; Amano J
Cancer Sci; 2010 Sep; 101(9):1925-32. PubMed ID: 20579076
[TBL] [Abstract][Full Text] [Related]
2. Tumor-Targeting Therapy Using Gene-Engineered Anaerobic-Nonpathogenic Bifidobacterium longum.
Taniguchi S; Shimatani Y; Fujimori M
Methods Mol Biol; 2016; 1409():49-60. PubMed ID: 26846801
[TBL] [Abstract][Full Text] [Related]
3. Genetically engineered Bifidobacterium longum for tumor-targeting enzyme-prodrug therapy of autochthonous mammary tumors in rats.
Sasaki T; Fujimori M; Hamaji Y; Hama Y; Ito K; Amano J; Taniguchi S
Cancer Sci; 2006 Jul; 97(7):649-57. PubMed ID: 16827806
[TBL] [Abstract][Full Text] [Related]
4. Use of bacteria in anti-cancer therapies.
Ryan RM; Green J; Lewis CE
Bioessays; 2006 Jan; 28(1):84-94. PubMed ID: 16369949
[TBL] [Abstract][Full Text] [Related]
5. Tumor-specific gene delivery using genetically engineered bacteria.
Theys J; Barbé S; Landuyt W; Nuyts S; Van Mellaert L; Wouters B; Anné J; Lambin P
Curr Gene Ther; 2003 Jun; 3(3):207-21. PubMed ID: 12762480
[TBL] [Abstract][Full Text] [Related]
6. Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors.
Yazawa K; Fujimori M; Amano J; Kano Y; Taniguchi S
Cancer Gene Ther; 2000 Feb; 7(2):269-74. PubMed ID: 10770636
[TBL] [Abstract][Full Text] [Related]
7. Explicit hypoxia targeting with tumor suppression by creating an "obligate" anaerobic Salmonella Typhimurium strain.
Yu B; Yang M; Shi L; Yao Y; Jiang Q; Li X; Tang LH; Zheng BJ; Yuen KY; Smith DK; Song E; Huang JD
Sci Rep; 2012; 2():436. PubMed ID: 22666539
[TBL] [Abstract][Full Text] [Related]
8. Bacterial targeted tumour therapy-dawn of a new era.
Wei MQ; Mengesha A; Good D; Anné J
Cancer Lett; 2008 Jan; 259(1):16-27. PubMed ID: 18063294
[TBL] [Abstract][Full Text] [Related]
9. Obligate and facultative anaerobic bacteria in targeted cancer therapy: Current strategies and clinical applications.
Dróżdż M; Makuch S; Cieniuch G; Woźniak M; Ziółkowski P
Life Sci; 2020 Nov; 261():118296. PubMed ID: 32822716
[TBL] [Abstract][Full Text] [Related]
10. Salmonella-allies in the fight against cancer.
Leschner S; Weiss S
J Mol Med (Berl); 2010 Aug; 88(8):763-73. PubMed ID: 20526574
[TBL] [Abstract][Full Text] [Related]
11. Use of Bacteria in Cancer Therapy.
Sarotra P; Medhi B
Recent Results Cancer Res; 2016; 209():111-121. PubMed ID: 28101691
[TBL] [Abstract][Full Text] [Related]
12. Cloned cytosine deaminase gene expression of Bifidobacterium longum and application to enzyme/pro-drug therapy of hypoxic solid tumors.
Nakamura T; Sasaki T; Fujimori M; Yazawa K; Kano Y; Amano J; Taniguchi S
Biosci Biotechnol Biochem; 2002 Nov; 66(11):2362-6. PubMed ID: 12506973
[TBL] [Abstract][Full Text] [Related]
13. Three-dimensional tumor spheroids for in vitro analysis of bacteria as gene delivery vectors in tumor therapy.
Osswald A; Sun Z; Grimm V; Ampem G; Riegel K; Westendorf AM; Sommergruber W; Otte K; Dürre P; Riedel CU
Microb Cell Fact; 2015 Dec; 14():199. PubMed ID: 26655167
[TBL] [Abstract][Full Text] [Related]
14. The genus Bifidobacterium for cancer gene therapy.
Fujimori M; Amano J; Taniguchi S
Curr Opin Drug Discov Devel; 2002 Mar; 5(2):200-3. PubMed ID: 11926126
[TBL] [Abstract][Full Text] [Related]
15. Tumor-colonizing bacteria: a potential tumor targeting therapy.
Zu C; Wang J
Crit Rev Microbiol; 2014 Aug; 40(3):225-35. PubMed ID: 23964706
[TBL] [Abstract][Full Text] [Related]
16. [Application of microorganisms as delivery vehicles in cancer gene therapies].
Łepeta K; Łasica AM; Jagusztyn-Krynicka EK
Postepy Biochem; 2012; 58(3):314-26. PubMed ID: 23373417
[TBL] [Abstract][Full Text] [Related]
17. Facultative or obligate anaerobic bacteria have the potential for multimodality therapy of solid tumours.
Wei MQ; Ellem KA; Dunn P; West MJ; Bai CX; Vogelstein B
Eur J Cancer; 2007 Feb; 43(3):490-6. PubMed ID: 17113280
[TBL] [Abstract][Full Text] [Related]
18. Efficient tumor targeting by anaerobic butyrate-producing bacteria.
Tirandaz H; Mohammadi E
Med Hypotheses; 2013 May; 80(5):675-8. PubMed ID: 23410499
[TBL] [Abstract][Full Text] [Related]
19.
Ngo N; Choucair K; Creeden JF; Qaqish H; Bhavsar K; Murphy C; Lian K; Albrethsen MT; Stanbery L; Phinney RC; Brunicardi FC; Dworkin L; Nemunaitis J
Future Oncol; 2019 Nov; 15(33):3861-3876. PubMed ID: 31668087
[TBL] [Abstract][Full Text] [Related]
20. The use of clostridial spores for cancer treatment.
Barbé S; Van Mellaert L; Anné J
J Appl Microbiol; 2006 Sep; 101(3):571-8. PubMed ID: 16907807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
